Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious.
about
The achilles heel of the trojan horse model of HIV-1 trans-infectionThe role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection.Human immunodeficiency virus fusion to dendritic cells declines as cells mature.Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers.Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC)Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells.Plasmacytoid dendritic cells in HIV infection.HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting CellsRNAi-directed inhibition of DC-SIGN by dendritic cells: prospects for HIV-1 therapy.Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes.Polybacterial challenge enhances HIV reactivation in latently infected macrophages and dendritic cells.The AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with accumulation of immature CD11bHi dendritic cells.Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents.
P2860
Q33347130-81B04CAE-0FF6-4B10-9EE1-B11BDE80A83CQ33662836-AD1F643A-1BB5-4836-AAEB-C21F0DBBCCF5Q33794467-DBDD60F4-77C6-4E45-81C0-E73C087F13B6Q34353507-0FB47231-8D35-4BE9-970F-47B10489DD87Q35849999-F64E983A-290E-4744-9CA3-CAA0A3D08400Q35920633-5F3A4E23-2C4F-424D-82E4-05162D7660B8Q36025318-4323E2B2-5E28-44A3-B90B-A3293E905C19Q36315149-DA6B8FC4-A6CA-4556-A365-7DE68CE71059Q36399936-6BB4F2B3-8706-42DA-B012-E27C7C62AE9CQ37019332-DEF85467-6D9E-40F0-ABA1-90457F67E264Q37287774-E7994D26-40CA-4EE3-BC71-5ACADC163CC3Q37361748-6D42A26E-E967-4417-8130-76F30C70D82EQ39023294-4D1FF893-89F3-4DD6-8D7D-A72D91C5DA4EQ39610112-8BA9301B-5465-446F-A184-34C5032661FCQ39632514-7964B531-6D58-44BF-9E05-0C44D4B45C6AQ40012148-8F983F8B-2BFB-419E-995E-3AD9368360DAQ41871158-70850B17-FD34-489E-9EF2-11810DDA5417
P2860
Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Human immunodeficiency virus t ...... face and is highly infectious.
@ast
Human immunodeficiency virus t ...... face and is highly infectious.
@en
type
label
Human immunodeficiency virus t ...... face and is highly infectious.
@ast
Human immunodeficiency virus t ...... face and is highly infectious.
@en
prefLabel
Human immunodeficiency virus t ...... face and is highly infectious.
@ast
Human immunodeficiency virus t ...... face and is highly infectious.
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... rface and is highly infectious
@en
P2093
Dierich MP
P2860
P304
P577
1999-04-01T00:00:00Z